NASDAQ:SGEN
Delisted
Seattle Genetics Stock News
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Seagen (SGEN) Q4 Earnings Beat Estimates, Revenues Rise Y/Y
11:22am, Friday, 12'th Feb 2021
Seagen (SGEN) surpasses estimates for earnings and revenues in the fourth quarter of 2020. The company provides revenues guidance for 2021.
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) today announced that the European Commission (EC) has granted marketing authorization for TUKYSA® (tucatinib) in combination with trastuzuma
Seagen' (SGEN) CEO Clay Siegall on Q4 2020 Results - Earnings Call Transcript
10:54pm, Thursday, 11'th Feb 2021
Seagen' (SGEN) CEO Clay Siegall on Q4 2020 Results - Earnings Call Transcript
Seattle Genetics (SGEN) Q4 Earnings and Revenues Top Estimates
06:56pm, Thursday, 11'th Feb 2021
Seattle Genetics (SGEN) delivered earnings and revenue surprises of 11.11% and 3.04%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Seagen (SGEN) Submits BLA to FDA for Cervical Cancer Drug
12:06pm, Thursday, 11'th Feb 2021
Seagen (SGEN) submits a BLA to the FDA for accelerated approval of tisotumab vedotin in patients with recurrent/metastatic cervical cancer, whose disease has progressed on or after chemotherapy.
Why Earnings Season Could Be Great for Seagen (SGEN)
09:25am, Wednesday, 10'th Feb 2021
Seagen (SGEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's Why Seagen Jumped Higher Today
05:50pm, Friday, 05'th Feb 2021
The rumor mill took hold in late-day trading.
BMEZ: Healthcare Exposure With A ~4% Yield And Growth Potential
04:05am, Saturday, 30'th Jan 2021
BMEZ delivered solid results throughout 2020, helped by the healthcare sector overall. This fund doesn't just invest in your typical healthcare companies though and tilts towards smaller and private i
American BriVision: Deep Dive Into Market Potential
03:38pm, Thursday, 14'th Jan 2021
American BriVision: Deep Dive Into Market Potential
The Top 3 Biotech Stocks to Buy in 2021
07:05am, Sunday, 10'th Jan 2021
Revenue growth is just beginning for these companies.
Seagen to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021
08:00am, Thursday, 07'th Jan 2021
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced that it will report its fourth quarter and full year 2020 financial results on Thursday, February 11, 2021 after the close o
Seagen Earns Top Honors from Key Biotech Publication
10:25am, Thursday, 31'st Dec 2020
Seagen, Inc. (SGEN) has recently been named Biotech of the Year by leading industry publication Biopharma Dive, and investors would no doubt agree. Shares of the Seattle-area firm are up nearly 65% ye
Seagen to Present at the J.P. Morgan Healthcare Conference
08:00am, Wednesday, 16'th Dec 2020
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced that management will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 at 2:0
7 Biotech Stocks To Buy Beyond Covid Vaccine Plays
01:37pm, Monday, 14'th Dec 2020
It's a relief to know Covid-19 vaccines are on the way. But there are plenty of other great biotechs that have been overlooked in the market frenzy.
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion re
